Media coverage about K2M Group (NASDAQ:KTWO) has been trending positive recently, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. K2M Group earned a media sentiment score of 0.27 on Accern’s scale. Accern also gave headlines about the medical device company an impact score of 46.4709534679105 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
KTWO has been the subject of several research analyst reports. Needham & Company LLC downgraded K2M Group from a “strong-buy” rating to a “buy” rating and lowered their target price for the stock from $26.00 to $20.00 in a research note on Friday, December 8th. Zacks Investment Research raised K2M Group from a “sell” rating to a “hold” rating in a research note on Wednesday, December 13th. Barclays reissued a “buy” rating and set a $25.00 target price on shares of K2M Group in a research note on Tuesday, January 9th. BidaskClub raised K2M Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 10th. Finally, Oppenheimer set a $24.00 target price on K2M Group and gave the stock a “buy” rating in a research note on Thursday, March 1st. One analyst has rated the stock with a sell rating, three have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $24.50.
K2M Group stock opened at $18.79 on Friday. K2M Group has a 1 year low of $16.44 and a 1 year high of $25.99. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.84 and a quick ratio of 1.52. The company has a market capitalization of $846.06, a PE ratio of -21.60 and a beta of 1.47.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/3338007/positive-media-coverage-somewhat-unlikely-to-impact-k2m-group-ktwo-share-price.html.
K2M Group Company Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.